"Gene Editing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genetic engineering techniques that involve DNA REPAIR mechanisms for incorporating site-specific modifications into a cell's genome.
Descriptor ID |
D000072669
|
MeSH Number(s) |
E05.393.420.270
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gene Editing".
Below are MeSH descriptors whose meaning is more specific than "Gene Editing".
This graph shows the total number of publications written about "Gene Editing" by people in this website by year, and whether "Gene Editing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 1 | 2 |
2017 | 2 | 2 | 4 |
2018 | 5 | 1 | 6 |
2019 | 2 | 3 | 5 |
2020 | 1 | 2 | 3 |
2021 | 1 | 3 | 4 |
2022 | 1 | 3 | 4 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Editing" by people in Profiles.
-
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. Nature. 2023 Mar; 615(7953):697-704.
-
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 Mar; 615(7953):687-696.
-
The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy. Curr Opin Cardiol. 2022 09 01; 37(5):413-418.
-
CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion. BMC Genomics. 2022 Mar 02; 23(1):172.
-
CRISPR screening in human hematopoietic stem and progenitor cells reveals an enrichment for tumor suppressor genes within chromosome 7 commonly deleted regions. Leukemia. 2022 05; 36(5):1421-1425.
-
A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation. Nat Commun. 2021 10 15; 12(1):6025.
-
Disparities among infertility patients regarding genetic carrier screening, sex selection, and gene editing. J Assist Reprod Genet. 2021 Sep; 38(9):2319-2325.
-
Programmable technologies to manipulate gene expression at the RNA level. Curr Opin Chem Biol. 2021 10; 64:27-37.
-
Targeting RLIP with CRISPR/Cas9 controls tumor growth. Carcinogenesis. 2021 02 11; 42(1):48-57.
-
Accelerating functional gene discovery in osteoarthritis. Nat Commun. 2021 01 20; 12(1):467.